Trials / Completed
CompletedNCT02435862
A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy
Protocol PVD-202: A Phase 2, Randomized, Double-Masked, Placebo-Controlled Multicenter Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD in Non-Proliferative Diabetic Retinopathy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 105 (actual)
- Sponsor
- Allegro Ophthalmics, LLC · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
A Phase 2, Randomized, Double-masked, Placebo-controlled Multicenter Clinical Trial Designed to Evaluate the Safety and Efficacy of Luminate in Inducing PVD in Subjects with Non-Proliferative Diabetic Retinopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 1.0mg Luminate® | |
| DRUG | 2.0mg Luminate® | |
| DRUG | 3.0mg Luminate® | |
| OTHER | Balanced Salt Solution for intravitreal injection in 0.10cc |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2017-08-10
- Completion
- 2017-08-10
- First posted
- 2015-05-06
- Last updated
- 2017-12-15
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02435862. Inclusion in this directory is not an endorsement.